Sleep Number Co. (NASDAQ: SNBR) director Daniel Alegre sold 12,852 shares of the company’s stock in a trade that took place on Tuesday, May 25. The shares were sold for an average price of $ 107.55, for a total value of $ 1,382,232.60. The sale was disclosed in a legal file with the Securities & Exchange Commission, available at this link.
SNBR shares rose $ 3.59 during trading hours on Wednesday, reaching $ 108.71. 6,825 shares of the company were traded, for an average volume of 510,840 shares. The company has a market cap of $ 2.66 billion, a PE ratio of 17.40, a PEG ratio of 1.13 and a beta of 1.96. The company’s 50-day moving average is $ 114.93 and its 200-day moving average is $ 106.16. Sleep Number Co. has a 52 week low of $ 30.43 and a 52 week high of $ 151.44.
Sleep Number (NASDAQ: SNBR) last announced its quarterly earnings data on Tuesday, April 20. The company reported EPS of $ 2.51 for the quarter, beating the Zacks consensus estimate of $ 1.83 by $ 0.68. Sleep Number posted a negative return on equity of 81.06% and a net margin of 8.54%. The company posted revenue of $ 568.26 million in the quarter, compared to the consensus estimate of $ 582.34 million. In the same quarter of last year, the company made EPS of $ 1.36. The company’s quarterly revenue increased 20.2% year-over-year. On average, stock analysts expect Sleep Number Co. to post earnings per share of 6.77 for the current year.
Several equity research analysts recently commented on SNBR stocks. UBS Group upgraded Sleep Number from a “sell” rating to a “neutral” rating and raised its price target for the share from $ 65.00 to $ 135.00 in a research note on Thursday 18 February. Stifel Nicolaus reiterated a “buy” note on Sleep Number shares in a research report on Tuesday, January 26. Bank of America downgraded Sleep Number from a ‘neutral’ to an ‘underperforming’ rating and raised its price target for the company from $ 73.00 to $ 88.00 in a research report on Thursday 4 February. Wedbush raised its price target on Sleep Number from $ 120.00 to $ 130.00 and rated the stock “neutral” in a report on Thursday, February 18. Finally, TheStreet downgraded Sleep Number from a “b” rating to a “c +” rating in a Friday April 9th report. Two equity research analysts rated the stock with a sell rating, three gave the stock a sustaining rating, and two rated the stock. The stock currently has an average rating of “Hold” and an average price target of $ 112.20.
Hedge funds have recently increased or reduced their holdings in the stock. Inspire Advisors LLC purchased a new position in Sleep Number in the 4th quarter valued at $ 31,000. Optimum Investment Advisors purchased a new position in Sleep Number during the first quarter valued at approximately $ 43,000. Strs Ohio purchased a new position in Sleep Number during the fourth quarter valued at approximately $ 81,000. Point72 Hong Kong Ltd acquired a new stake in Sleep Number shares in the 1st quarter valued at approximately $ 81,000. Finally, Veriti Management LLC acquired a new stake in Sleep Number shares in the fourth quarter valued at approximately $ 88,000. 97.78% of the shares are held by hedge funds and other institutional investors.
About the sleep number
Sleep Number Corporation, along with its subsidiaries, provides sleep solutions and services in the United States. The company designs, manufactures, markets, retailers and services beds, pillows, sheets and other bedding products under the name Sleep Number. It also offers adjustable bases under the name FlextFit; temperature balancing products including DualTemp layer; SleepIQ Kids has children’s beds; and smart beds under the names Sleep Number 360 and 360.
Further reading: Street name
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to contac[email protected]
Featured article: How is a price target determined?
7 actions that can help you take advantage of summer shortages
One of the lingering impacts of the Covid-19 pandemic is supply chain disruptions that continue to disrupt many industries. Right now, every investor is aware of the global chip shortage that is disrupting many industries that are expected to experience strong growth in 2021.
But many other sectors are affected by supply chain disruptions. And it affects everything from big ticket items like cars to everyday items like pet food and even bacon.
This special presentation focuses on seven companies that stand to benefit from the current supply chain disruption. All of these companies made solid gains in 2020. Some of them weakened in 2021, but that was before the full extent of supply chain weakness was discovered.
As the economy reopens, the item shortage is likely to continue and become much more noticeable. When they do, many of those stocks can be overstated. That’s why now is the time to grab those stocks that can help you work the supply chain in your favor.
Check out the “7 Actions That Can Help You Take Advantage of Summer Shortages”.